← All trials
NCT01985360
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2014
- Primary completion
- Jun 30, 2019
- Completion date
- Jul 31, 2020
- First posted
- Nov 15, 2013
- Last posted
- Oct 18, 2021
- Enrollment
- 777
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- New York UniversityLead sponsor
- Columbia UniversityCollaborator
- Duke UniversityCollaborator
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- New York UniversityCollaborator
- New York UniversityOverall official - principal investigator
- Stanford UniversityCollaborator
- New York UniversityOfficial
- Stanford UniversityOfficial
- New York UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.